In the last 12 months, insiders at Cullinan Therapeutics, Inc. ($CGEM) filed 195 transactions with the SEC: 8 open-market purchases totaling $13,322,539 and 83 sales totaling $6,301,542. Net insider sentiment: net buying.
Cullinan Therapeutics, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Lynx1 Capital Management LP (TenPercentOwner) — 8 transactions totaling $13,322,539
- Michaelson Jennifer (Chief Scientific Officer) — 41 transactions totaling $3,284,356
- Savill Corrine (Chief Business Officer) — 21 transactions totaling $2,201,571
- GADICKE ANSBERT (Other) — 3 transactions totaling $1,509,033
- Ebeling Thomas (Not found) — 7 transactions totaling $811,740
View all SEC Filings for Cullinan Therapeutics, Inc. (CGEM).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Michaelson Jennifer | Chief Scientific Officer | M | Stock Option (Right to Buy) | 4000 | $0.00 | 120,987.0000 | 59,076,259 | 3.20% | 0.01% |
| March 5, 2026 | Michaelson Jennifer | Chief Scientific Officer | M | Common Stock | 4000 | $4.30 | 178,844.0000 | 59,076,259 | 2.29% | 0.01% |
| March 5, 2026 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 8000 | $15.68 | 170,844.0000 | 59,076,259 | 4.47% | 0.01% |
| Feb. 25, 2026 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 1780 | $14.14 | 174,844.0000 | 59,076,259 | 1.01% | 0.00% |
| Feb. 23, 2026 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 1752 | $13.99 | 180,225.0000 | 59,076,259 | 0.96% | 0.00% |
| Feb. 24, 2026 | SUMER JACQUELYN L | Chief Legal Officer | S | Common Stock | 3601 | $14.47 | 128,089.0000 | 59,076,259 | 2.73% | 0.01% |
| Feb. 24, 2026 | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 4582 | $14.47 | 159,968.0000 | 59,076,259 | 2.78% | 0.01% |
| Feb. 24, 2026 | AHMED NADIM | President and CEO | S | Common Stock | 13515 | $14.47 | 390,803.0000 | 59,076,259 | 3.34% | 0.02% |
| Feb. 24, 2026 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 3601 | $14.47 | 176,624.0000 | 59,076,259 | 2.00% | 0.01% |
| Feb. 20, 2026 | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 4982 | $13.62 | 164,550.0000 | 59,076,259 | 2.94% | 0.01% |
| Feb. 20, 2026 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 3742 | $13.62 | 181,977.0000 | 59,076,259 | 2.01% | 0.01% |
| Feb. 20, 2026 | Michaelson Jennifer | Chief Scientific Officer | M | Common Stock | 8000 | $4.30 | 189,977.0000 | 59,076,259 | 4.40% | 0.01% |
| Feb. 20, 2026 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 8000 | $14.30 | 181,977.0000 | 59,076,259 | 4.21% | 0.01% |
| Feb. 20, 2026 | Michaelson Jennifer | Chief Scientific Officer | M | Stock Option (Right to Buy) | 8000 | $0.00 | 124,987.0000 | 59,076,259 | 6.02% | 0.01% |
| Feb. 20, 2026 | SUMER JACQUELYN L | Chief Legal Officer | S | Common Stock | 3742 | $13.62 | 131,690.0000 | 59,076,259 | 2.76% | 0.01% |
| Feb. 20, 2026 | AHMED NADIM | President and CEO | S | Common Stock | 16381 | $13.62 | 404,318.0000 | 59,076,259 | 3.89% | 0.03% |
| Feb. 20, 2026 | Fenton Mary Kay | Chief Financial Officer | S | Common Stock | 4398 | $13.62 | 126,380.0000 | 59,076,259 | 3.36% | 0.01% |
| Feb. 18, 2026 | SUMER JACQUELYN L | Chief Legal Officer | A | Stock Option (Right to Buy) | 230000 | $0.00 | 230,000.0000 | 59,076,259 | 9999.99% | 0.39% |
| Feb. 18, 2026 | Jones Jeffrey Alan | Chief Medical Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 59,076,259 | 9999.99% | 0.51% |
| Feb. 18, 2026 | AHMED NADIM | President and CEO | A | Stock Option (Right to Buy) | 828000 | $0.00 | 828,000.0000 | 59,076,259 | 9999.99% | 1.40% |
| Feb. 18, 2026 | Savill Corrine | Chief Business Officer | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 59,076,259 | 9999.99% | 0.30% |
| Feb. 18, 2026 | Fenton Mary Kay | Chief Financial Officer | A | Common Stock | 68750 | $0.00 | 130,778.0000 | 59,076,259 | 110.84% | 0.12% |
| Feb. 18, 2026 | Fenton Mary Kay | Chief Financial Officer | A | Stock Option (Right to Buy) | 137500 | $0.00 | 137,500.0000 | 59,076,259 | 9999.99% | 0.23% |
| Feb. 18, 2026 | Michaelson Jennifer | Chief Scientific Officer | A | Common Stock | 57500 | $0.00 | 185,719.0000 | 59,076,259 | 44.85% | 0.10% |
| Feb. 18, 2026 | Michaelson Jennifer | Chief Scientific Officer | A | Stock Option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 59,076,259 | 9999.99% | 0.19% |
| Feb. 12, 2026 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 416 | $12.03 | 128,219.0000 | 59,076,259 | 0.32% | 0.00% |
| Jan. 22, 2026 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 4000 | $12.30 | 128,635.0000 | 59,076,259 | 3.02% | 0.01% |
| Dec. 31, 2025 | Fenton Mary Kay | Chief Financial Officer | A | Common Stock | 27 | $6.49 | 62,028.0000 | 59,076,259 | 0.04% | 0.00% |
| Dec. 23, 2025 | AHMED NADIM | President and CEO | S | Common Stock | 9922 | $10.01 | 420,699.0000 | 59,076,259 | 2.30% | 0.02% |
| Dec. 19, 2025 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 1345 | $10.01 | 132,635.0000 | 59,076,259 | 1.00% | 0.00% |
| Dec. 18, 2025 | SUMER JACQUELYN L | Chief Legal Officer | S | Common Stock | 3480 | $9.67 | 135,432.0000 | 59,076,259 | 2.51% | 0.01% |
| Dec. 18, 2025 | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 4632 | $9.67 | 169,532.0000 | 59,076,259 | 2.66% | 0.01% |
| Dec. 18, 2025 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 2898 | $9.67 | 133,980.0000 | 59,076,259 | 2.12% | 0.00% |
| Dec. 12, 2025 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 2148 | $12.38 | 137,873.0000 | 59,076,259 | 1.53% | 0.00% |
| Dec. 15, 2025 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 995 | $11.90 | 136,878.0000 | 59,076,259 | 0.72% | 0.00% |
| Nov. 24, 2025 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 4000 | $12.30 | 138,004.0000 | 59,076,259 | 2.82% | 0.01% |
| Oct. 28, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common stock, $0.0001 par value per share | 165667 | $8.40 | 8,963,500.0000 | 59,076,259 | 1.88% | 0.28% |
| Oct. 14, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common stock, $0.0001 par value per share ("Common Stock") | 15032 | $7.59 | 8,564,116.0000 | 59,076,259 | 0.18% | 0.03% |
| Oct. 15, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 51500 | $7.94 | 8,615,616.0000 | 59,076,259 | 0.60% | 0.09% |
| Oct. 16, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 150000 | $8.86 | 8,765,616.0000 | 59,076,259 | 1.74% | 0.25% |
| Oct. 17, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 32217 | $7.84 | 8,797,833.0000 | 59,076,259 | 0.37% | 0.05% |
| Oct. 8, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common stock, $0.0001 par value per share ("Common Stock") | 556300 | $6.46 | 7,645,743.0000 | 59,076,259 | 7.85% | 0.94% |
| Oct. 10, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 277298 | $7.36 | 8,549,084.0000 | 59,076,259 | 3.35% | 0.47% |
| Oct. 9, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 626043 | $6.70 | 8,271,786.0000 | 59,076,259 | 8.19% | 1.06% |
| Aug. 7, 2025 | Allen Andrew R | Not found | A | Stock Option (Right to Buy) | 79456 | $0.00 | 79,456.0000 | 58,510,610 | 9999.99% | 0.14% |
| Aug. 7, 2025 | Doyle Mittie | Not found | A | Stock Option (Right to Buy) | 79456 | $0.00 | 79,456.0000 | 58,510,610 | 9999.99% | 0.14% |
| June 12, 2025 | Rosenberg Anthony | Not found | A | Stock Option (Right to Buy) | 38513 | $0.00 | 38,513.0000 | 58,510,610 | 9999.99% | 0.07% |
| June 12, 2025 | Ryan David P. | Not found | A | Stock Option (Right to Buy) | 38513 | $0.00 | 38,513.0000 | 58,510,610 | 9999.99% | 0.07% |
| June 12, 2025 | Webster Stephen W | Not found | A | Stock Option (Right to Buy) | 38513 | $0.00 | 38,513.0000 | 58,510,610 | 9999.99% | 0.07% |
| June 12, 2025 | Meek David D. | Not found | A | Stock Option (Right to Buy) | 38513 | $0.00 | 38,513.0000 | 58,510,610 | 9999.99% | 0.07% |
| June 12, 2025 | Martin Anne-Marie | Not found | A | Stock Option (Right to Buy) | 38513 | $0.00 | 38,513.0000 | 58,510,610 | 9999.99% | 0.07% |
| Feb. 25, 2025 | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 4895 | $8.53 | 174,164.0000 | 58,510,610 | 2.73% | 0.01% |
| Feb. 25, 2025 | SUMER JACQUELYN L | Chief Legal Officer | S | Common Stock | 3756 | $8.53 | 136,895.0000 | 58,510,610 | 2.67% | 0.01% |
| Feb. 25, 2025 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 3756 | $8.53 | 142,004.0000 | 58,510,610 | 2.58% | 0.01% |
| Feb. 25, 2025 | AHMED NADIM | President and CEO | S | Common Stock | 12529 | $8.53 | 430,621.0000 | 58,510,610 | 2.83% | 0.02% |
| Feb. 19, 2025 | Fenton Mary Kay | Chief Financial Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 58,510,610 | 9999.99% | 0.21% |
| Feb. 19, 2025 | Michaelson Jennifer | Chief Scientific Officer | A | Common Stock | 50000 | $0.00 | 145,760.0000 | 58,510,610 | 52.21% | 0.09% |
| Feb. 19, 2025 | Michaelson Jennifer | Chief Scientific Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 58,510,610 | 9999.99% | 0.17% |
| Feb. 19, 2025 | Savill Corrine | Chief Business Officer | A | Common Stock | 37500 | $0.00 | 240,990.0000 | 58,510,610 | 18.43% | 0.06% |
| Feb. 19, 2025 | Savill Corrine | Chief Business Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 58,510,610 | 9999.99% | 0.13% |
| Feb. 19, 2025 | SUMER JACQUELYN L | Chief Legal Officer | A | Common Stock | 50000 | $0.00 | 140,651.0000 | 58,510,610 | 55.16% | 0.09% |
| Feb. 19, 2025 | SUMER JACQUELYN L | Chief Legal Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 58,510,610 | 9999.99% | 0.17% |
| Feb. 19, 2025 | AHMED NADIM | President and CEO | A | Common Stock | 180000 | $0.00 | 443,150.0000 | 58,510,610 | 68.40% | 0.31% |
| Feb. 19, 2025 | AHMED NADIM | President and CEO | A | Stock Option (Right to Buy) | 360000 | $0.00 | 360,000.0000 | 58,510,610 | 9999.99% | 0.62% |
| Feb. 19, 2025 | Jones Jeffrey Alan | Chief Medical Officer | A | Common Stock | 65000 | $0.00 | 179,059.0000 | 58,510,610 | 56.99% | 0.11% |
| Feb. 19, 2025 | Jones Jeffrey Alan | Chief Medical Officer | A | Stock Option (Right to Buy) | 130000 | $0.00 | 130,000.0000 | 58,510,610 | 9999.99% | 0.22% |
| Feb. 19, 2025 | Fenton Mary Kay | Chief Financial Officer | A | Common Stock | 60000 | $0.00 | 60,000.0000 | 58,510,610 | 9999.99% | 0.10% |
| Jan. 6, 2025 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 4000 | $12.51 | 95,760.0000 | 58,510,610 | 4.01% | 0.01% |
| Dec. 24, 2024 | AHMED NADIM | President and CEO | S | Common Stock | 8400 | $11.87 | 263,150.0000 | 42,900,083 | 3.09% | 0.02% |
| Dec. 18, 2024 | SUMER JACQUELYN L | Chief Legal Officer | S | Common Stock | 3482 | $11.41 | 90,651.0000 | 42,900,083 | 3.70% | 0.01% |
| Dec. 18, 2024 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 4693 | $11.41 | 99,760.0000 | 42,900,083 | 4.49% | 0.01% |
| Dec. 18, 2024 | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 4632 | $11.41 | 114,059.0000 | 42,900,083 | 3.90% | 0.01% |
| Dec. 12, 2024 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 3489 | $12.52 | 104,453.0000 | 42,900,083 | 3.23% | 0.01% |
| Nov. 5, 2024 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 8000 | $15.64 | 107,942.0000 | 42,900,083 | 6.90% | 0.02% |
| Sept. 5, 2024 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 8000 | $18.09 | 115,942.0000 | 42,900,083 | 6.45% | 0.02% |
| Aug. 8, 2024 | Thistle Mary | Not found | A | Stock Option (Right to Buy) | 25743 | $0.00 | 25,743.0000 | 42,900,083 | 9999.99% | 0.06% |
| July 5, 2024 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 8000 | $16.33 | 123,942.0000 | 42,900,083 | 6.06% | 0.02% |
| July 1, 2024 | Michaelson Jennifer | Chief Scientific Officer | A | Common Stock | 2360 | $9.00 | 131,942.0000 | 42,900,083 | 1.82% | 0.01% |
| June 26, 2024 | Rosenberg Anthony | Not found | A | Stock Option (Right to Buy) | 15806 | $0.00 | 15,806.0000 | 42,900,083 | 9999.99% | 0.04% |
| June 26, 2024 | Martin Anne-Marie | Not found | A | Stock Option (Right to Buy) | 15806 | $0.00 | 15,806.0000 | 42,900,083 | 9999.99% | 0.04% |
| June 26, 2024 | Ryan David P. | Not found | A | Stock Option (Right to Buy) | 15806 | $0.00 | 15,806.0000 | 42,900,083 | 9999.99% | 0.04% |
| June 26, 2024 | Webster Stephen W | Not found | A | Stock Option (Right to Buy) | 15806 | $0.00 | 15,806.0000 | 42,900,083 | 9999.99% | 0.04% |
| June 10, 2024 | Ebeling Thomas | Not found | M | Stock Option (Right to Buy) | 18450 | $0.00 | 0.0000 | 42,900,083 | 100.00% | 0.04% |
| June 10, 2024 | Ebeling Thomas | Not found | M | Common Stock | 18450 | $13.00 | 186,653.0000 | 42,900,083 | 10.97% | 0.04% |
| May 23, 2024 | Ebeling Thomas | Not found | A | Common Stock | 16475 | $12.73 | 168,203.0000 | 42,900,083 | 10.86% | 0.04% |
| May 23, 2024 | Ebeling Thomas | Not found | M | Stock Option (Right to Buy) | 84224 | $0.00 | 0.0000 | 42,900,083 | 100.00% | 0.20% |
| May 23, 2024 | Ebeling Thomas | Not found | M | Stock Option (Right to Buy) | 16475 | $0.00 | 0.0000 | 42,900,083 | 100.00% | 0.04% |
| May 23, 2024 | Ebeling Thomas | Not found | A | Common Stock | 84224 | $4.30 | 151,728.0000 | 42,900,083 | 124.77% | 0.20% |
| May 15, 2024 | Meek David D. | Not found | A | Stock Option (Right to Buy) | 15618 | $0.00 | 15,618.0000 | 42,900,083 | 9999.99% | 0.04% |
| May 6, 2024 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 37723 | $27.82 | 149,859.0000 | 42,900,083 | 20.11% | 0.09% |
| May 6, 2024 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 20277 | $28.54 | 129,582.0000 | 42,900,083 | 13.53% | 0.05% |
| May 7, 2024 | Michaelson Jennifer | Chief Scientific Officer | M | Common Stock | 5606 | $4.30 | 135,188.0000 | 42,900,083 | 4.33% | 0.01% |
| May 6, 2024 | Michaelson Jennifer | Chief Scientific Officer | M | Common Stock | 50000 | $4.30 | 187,582.0000 | 42,900,083 | 36.34% | 0.12% |
| May 6, 2024 | Michaelson Jennifer | Chief Scientific Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 138,593.0000 | 42,900,083 | 26.51% | 0.12% |
| May 7, 2024 | Michaelson Jennifer | Chief Scientific Officer | M | Stock Option (Right to Buy) | 5606 | $0.00 | 132,987.0000 | 42,900,083 | 4.04% | 0.01% |
| May 7, 2024 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 5606 | $30.06 | 129,582.0000 | 42,900,083 | 4.15% | 0.01% |
| April 29, 2024 | Fenton Mary Kay | Chief Financial Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 42,900,083 | 9999.99% | 0.47% |
| Feb. 22, 2024 | SUMER JACQUELYN L | Chief Legal Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 42,900,083 | 9999.99% | 0.23% |
| Feb. 22, 2024 | Michaelson Jennifer | Chief Scientific Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 42,900,083 | 9999.99% | 0.23% |
| Feb. 22, 2024 | Michaelson Jennifer | Chief Scientific Officer | A | Common Stock | 50000 | $0.00 | 137,582.0000 | 42,900,083 | 57.09% | 0.12% |
| Feb. 22, 2024 | Jones Jeffrey Alan | Chief Medical Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 42,900,083 | 9999.99% | 0.29% |
| Feb. 22, 2024 | Jones Jeffrey Alan | Chief Medical Officer | A | Common Stock | 62500 | $0.00 | 118,691.0000 | 42,900,083 | 111.23% | 0.15% |
| Feb. 22, 2024 | Trigilio Jeffrey | Chief Financial Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 42,900,083 | 9999.99% | 0.23% |
| Feb. 22, 2024 | Trigilio Jeffrey | Chief Financial Officer | A | Common Stock | 50000 | $0.00 | 133,919.0000 | 42,900,083 | 59.58% | 0.12% |
| Feb. 22, 2024 | AHMED NADIM | President and CEO | A | Common Stock | 160000 | $0.00 | 271,550.0000 | 42,900,083 | 143.43% | 0.37% |
| Feb. 22, 2024 | AHMED NADIM | President and CEO | A | Stock Option (Right to Buy) | 320000 | $0.00 | 320,000.0000 | 42,900,083 | 9999.99% | 0.75% |
| Feb. 22, 2024 | Savill Corrine | Chief Business Officer | A | Common Stock | 37500 | $0.00 | 203,490.0000 | 42,900,083 | 22.59% | 0.09% |
| Feb. 22, 2024 | Savill Corrine | Chief Business Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 42,900,083 | 9999.99% | 0.17% |
| Feb. 22, 2024 | SUMER JACQUELYN L | Chief Legal Officer | A | Common Stock | 50000 | $0.00 | 94,133.0000 | 42,900,083 | 113.29% | 0.12% |
| Feb. 1, 2024 | Savill Corrine | Chief Business Officer | M | Stock Option (Right to Buy) | 40000 | $0.00 | 70,331.0000 | 42,900,083 | 36.25% | 0.09% |
| Feb. 1, 2024 | Savill Corrine | Chief Business Officer | S | Common Stock | 40000 | $16.18 | 165,990.0000 | 42,900,083 | 19.42% | 0.09% |
| Feb. 1, 2024 | Savill Corrine | Chief Business Officer | M | Common Stock | 40000 | $4.30 | 205,990.0000 | 42,900,083 | 24.10% | 0.09% |
| Jan. 29, 2024 | Savill Corrine | Chief Business Officer | S | Common Stock | 40000 | $14.09 | 165,990.0000 | 42,900,083 | 19.42% | 0.09% |
| Jan. 29, 2024 | Savill Corrine | Chief Business Officer | M | Stock Option (Right to Buy) | 13997 | $0.00 | 0.0000 | 42,900,083 | 100.00% | 0.03% |
| Jan. 29, 2024 | Savill Corrine | Chief Business Officer | M | Stock Option (Right to Buy) | 26003 | $0.00 | 110,331.0000 | 42,900,083 | 19.07% | 0.06% |
| Jan. 29, 2024 | Savill Corrine | Chief Business Officer | M | Common Stock | 40000 | $4.30 | 205,990.0000 | 42,900,083 | 24.10% | 0.09% |
| Jan. 22, 2024 | Savill Corrine | Chief Business Officer | S | Common Stock | 14559 | $12.18 | 170,115.0000 | 42,900,083 | 7.88% | 0.03% |
| Jan. 22, 2024 | Savill Corrine | Chief Business Officer | M | Common Stock | 14559 | $4.30 | 184,674.0000 | 42,900,083 | 8.56% | 0.03% |
| Jan. 23, 2024 | Savill Corrine | Chief Business Officer | M | Stock Option (Right to Buy) | 21316 | $0.00 | 13,997.0000 | 42,900,083 | 60.36% | 0.05% |
| Jan. 22, 2024 | Savill Corrine | Chief Business Officer | M | Stock Option (Right to Buy) | 14559 | $0.00 | 35,313.0000 | 42,900,083 | 29.19% | 0.03% |
| Jan. 23, 2024 | Savill Corrine | Chief Business Officer | S | Common Stock | 21316 | $12.46 | 165,990.0000 | 42,900,083 | 11.38% | 0.05% |
| Jan. 23, 2024 | Savill Corrine | Chief Business Officer | M | Common Stock | 21316 | $4.30 | 187,306.0000 | 42,900,083 | 12.84% | 0.05% |
| Jan. 22, 2024 | Savill Corrine | Chief Business Officer | S | Common Stock | 4125 | $12.02 | 165,990.0000 | 42,900,083 | 2.42% | 0.01% |
| Dec. 26, 2023 | AHMED NADIM | President and CEO | S | Common Stock | 4272 | $9.24 | 111,550.0000 | 0 | 3.69% | 0.00% |
| Dec. 21, 2023 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 1145 | $8.50 | 87,582.0000 | 0 | 1.29% | 0.00% |
| Dec. 21, 2023 | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 1860 | $8.50 | 56,191.0000 | 0 | 3.20% | 0.00% |
| Dec. 21, 2023 | SUMER JACQUELYN L | Chief Legal Officer | S | Common Stock | 1400 | $8.50 | 44,133.0000 | 0 | 3.07% | 0.00% |
| Dec. 21, 2023 | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 1920 | $8.50 | 83,919.0000 | 0 | 2.24% | 0.00% |
| Dec. 18, 2023 | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 386 | $8.22 | 58,051.0000 | 0 | 0.66% | 0.00% |
| Dec. 18, 2023 | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 398 | $8.22 | 85,839.0000 | 0 | 0.46% | 0.00% |
| Dec. 18, 2023 | SUMER JACQUELYN L | Chief Legal Officer | S | Common Stock | 290 | $8.22 | 45,533.0000 | 0 | 0.63% | 0.00% |
| Dec. 18, 2023 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 238 | $8.22 | 88,727.0000 | 0 | 0.27% | 0.00% |
| Dec. 12, 2023 | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 1926 | $7.81 | 86,237.0000 | 0 | 2.18% | 0.00% |
| Dec. 12, 2023 | Michaelson Jennifer | Chief Scientific Officer | S | Common Stock | 1068 | $7.81 | 88,965.0000 | 0 | 1.19% | 0.00% |
| June 30, 2023 | Trigilio Jeffrey | Chief Financial Officer | A | Common Stock | 2340 | $9.08 | 88,163.0000 | 0 | 2.73% | 0.00% |
| June 28, 2023 | AHMED NADIM | President and CEO | S | Common Stock | 759 | $11.40 | 115,822.0000 | 0 | 0.65% | 0.00% |
| June 20, 2023 | SUMER JACQUELYN L | Chief Legal Officer | S | Common Stock | 291 | $12.94 | 45,823.0000 | 0 | 0.63% | 0.00% |
| June 20, 2023 | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 399 | $12.94 | 85,823.0000 | 0 | 0.46% | 0.00% |
| June 20, 2023 | Michaelson Jennifer | Chief Development Officer | S | Common Stock | 238 | $12.94 | 90,033.0000 | 0 | 0.26% | 0.00% |
| June 20, 2023 | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 387 | $12.94 | 58,437.0000 | 0 | 0.66% | 0.00% |
| June 12, 2023 | Michaelson Jennifer | Chief Development Officer | S | Common Stock | 176 | $13.11 | 90,271.0000 | 0 | 0.19% | 0.00% |
| June 12, 2023 | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 319 | $13.11 | 86,222.0000 | 0 | 0.37% | 0.00% |
| June 8, 2023 | Webster Stephen W | Not found | A | Stock Option (Right to Buy) | 18450 | $0.00 | 18,450.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Rosenberg Anthony | Not found | A | Stock Option (Right to Buy) | 18450 | $0.00 | 18,450.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Ebeling Thomas | Not found | A | Stock Option (Right to Buy) | 18450 | $0.00 | 18,450.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Martin Anne-Marie | Not found | A | Stock Option (Right to Buy) | 18450 | $0.00 | 18,450.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Michaelson Jennifer | Chief Development Officer | S | Common Stock | 100 | $12.40 | 90,447.0000 | 0 | 0.11% | 0.00% |
| June 6, 2023 | Michaelson Jennifer | Chief Development Officer | M | Stock Option (Right to Buy) | 11900 | $0.00 | 188,693.0000 | 0 | 5.93% | 0.00% |
| June 6, 2023 | Michaelson Jennifer | Chief Development Officer | M | Common Stock | 11900 | $4.30 | 102,347.0000 | 0 | 13.16% | 0.00% |
| June 7, 2023 | Michaelson Jennifer | Chief Development Officer | M | Stock Option (Right to Buy) | 100 | $0.00 | 188,593.0000 | 0 | 0.05% | 0.00% |
| June 6, 2023 | Michaelson Jennifer | Chief Development Officer | S | Common Stock | 11900 | $12.31 | 90,447.0000 | 0 | 11.63% | 0.00% |
| June 7, 2023 | Michaelson Jennifer | Chief Development Officer | M | Common Stock | 100 | $4.30 | 90,547.0000 | 0 | 0.11% | 0.00% |
| May 23, 2023 | AHMED NADIM | President and CEO | S | Common Stock | 707 | $9.15 | 116,581.0000 | 0 | 0.60% | 0.00% |
| May 18, 2023 | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 394 | $8.76 | 58,824.0000 | 0 | 0.67% | 0.00% |
| May 18, 2023 | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 399 | $8.76 | 86,541.0000 | 0 | 0.46% | 0.00% |
| May 18, 2023 | SUMER JACQUELYN L | Chief Legal Officer | S | Common Stock | 291 | $8.76 | 46,114.0000 | 0 | 0.63% | 0.00% |
| May 18, 2023 | Michaelson Jennifer | Chief Development Officer | S | Common Stock | 239 | $8.76 | 90,447.0000 | 0 | 0.26% | 0.00% |
| May 12, 2023 | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 347 | $8.78 | 86,940.0000 | 0 | 0.40% | 0.00% |
| May 12, 2023 | Michaelson Jennifer | Chief Development Officer | S | Common Stock | 193 | $8.78 | 90,686.0000 | 0 | 0.21% | 0.00% |
| April 25, 2023 | AHMED NADIM | President and CEO | S | Common Stock | 716 | $10.59 | 117,288.0000 | 0 | 0.61% | 0.00% |
| April 18, 2023 | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 392 | $10.71 | 59,218.0000 | 0 | 0.66% | 0.00% |
| April 18, 2023 | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 398 | $10.71 | 87,287.0000 | 0 | 0.45% | 0.00% |
| April 18, 2023 | Michaelson Jennifer | Chief Development Officer | S | Common Stock | 238 | $10.71 | 90,879.0000 | 0 | 0.26% | 0.00% |
| April 18, 2023 | SUMER JACQUELYN L | Chief Legal Officer | S | Common Stock | 290 | $10.71 | 46,405.0000 | 0 | 0.62% | 0.00% |
| April 12, 2023 | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 318 | $10.22 | 87,685.0000 | 0 | 0.36% | 0.00% |
| April 12, 2023 | Michaelson Jennifer | Chief Development Officer | S | Common Stock | 176 | $10.22 | 91,117.0000 | 0 | 0.19% | 0.00% |
| March 20, 2023 | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 390 | $11.32 | 59,610.0000 | 0 | 0.65% | 0.00% |
| March 20, 2023 | Michaelson Jennifer | Chief Development Officer | S | Common Stock | 238 | $11.32 | 91,293.0000 | 0 | 0.26% | 0.00% |
| March 20, 2023 | SUMER JACQUELYN L | Chief Legal Officer | S | Common Stock | 305 | $11.32 | 46,695.0000 | 0 | 0.65% | 0.00% |
| March 20, 2023 | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 399 | $11.32 | 88,003.0000 | 0 | 0.45% | 0.00% |
| March 23, 2023 | AHMED NADIM | President and CEO | S | Common Stock | 706 | $10.51 | 118,004.0000 | 0 | 0.59% | 0.00% |
| Feb. 22, 2023 | AHMED NADIM | President and CEO | A | Common Stock | 109000 | $0.00 | 118,710.0000 | 0 | 1122.55% | 0.00% |
| Feb. 22, 2023 | AHMED NADIM | President and CEO | A | Stock Option (Right to Buy) | 211000 | $0.00 | 211,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | Baeuerle Patrick | Chief Scientific Officer | A | Common Stock | 38500 | $0.00 | 417,434.0000 | 0 | 10.16% | 0.00% |
| Feb. 17, 2023 | Jones Jeffrey Alan | Chief Medical Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | Jones Jeffrey Alan | Chief Medical Officer | A | Common Stock | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | Michaelson Jennifer | Chief Development Officer | A | Stock Option (Right to Buy) | 77000 | $0.00 | 77,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | Michaelson Jennifer | Chief Development Officer | A | Common Stock | 38500 | $0.00 | 91,531.0000 | 0 | 72.60% | 0.00% |
| Feb. 17, 2023 | Baeuerle Patrick | Chief Scientific Officer | A | Stock Option (Right to Buy) | 77000 | $0.00 | 77,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | SUMER JACQUELYN L | Chief Legal Officer | A | Stock Option (Right to Buy) | 93500 | $0.00 | 93,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | SUMER JACQUELYN L | Chief Legal Officer | A | Common Stock | 47000 | $0.00 | 47,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | Savill Corrine | Chief Business Officer | A | Stock Option (Right to Buy) | 41000 | $0.00 | 41,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | Savill Corrine | Chief Business Officer | A | Common Stock | 20500 | $0.00 | 170,115.0000 | 0 | 13.70% | 0.00% |
| Feb. 17, 2023 | Trigilio Jeffrey | Chief Financial Officer | A | Stock Option (Right to Buy) | 93500 | $0.00 | 93,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | Trigilio Jeffrey | Chief Financial Officer | A | Common Stock | 47000 | $0.00 | 88,402.0000 | 0 | 113.52% | 0.00% |
| Dec. 21, 2021 | GADICKE ANSBERT | Other | M | Stock Option (Right to Buy) | 88824 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 21, 2021 | GADICKE ANSBERT | Other | M | Common Stock | 350938 | $4.30 | 8,243,757.0000 | 0 | 4.45% | 0.00% |
| Dec. 21, 2021 | GADICKE ANSBERT | Other | M | Stock Option (Right to Buy) | 262114 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 19, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | J | Series A Convertible Preferred Stock | 260000 | $0.00 | 260,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | J | Series A Convertible Preferred Stock | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | J | Common Stock | 3500000 | $0.00 | 558,854.0000 | 0 | 86.23% | 0.00% |
| Jan. 19, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | J | Common Stock | 2600000 | $0.00 | 392,808.0000 | 0 | 86.87% | 0.00% |
| Jan. 19, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | J | Common Stock | 300000 | $0.00 | 64,161.0000 | 0 | 82.38% | 0.00% |
| Jan. 19, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | J | Series A Convertible Preferred Stock | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 30, 2022 | Trigilio Jeffrey | Chief Financial Officer | A | Common Stock | 201 | $8.97 | 41,402.0000 | 0 | 0.49% | 0.00% |